Fennec Pharmaceuticals In... (FENC)
NASDAQ: FENC
· Real-Time Price · USD
8.14
0.04 (0.49%)
At close: May 30, 2025, 3:59 PM
8.12
-0.25%
After-hours: May 30, 2025, 04:02 PM EDT
0.49% (1D)
| Bid | 7.6 |
| Market Cap | 224.82M |
| Revenue (ttm) | 30.91M |
| Net Income (ttm) | -14.07M |
| EPS (ttm) | -0.53 |
| PE Ratio (ttm) | -15.36 |
| Forward PE | 9.71 |
| Analyst | Strong Buy |
| Ask | 8.3 |
| Volume | 103,140 |
| Avg. Volume (20D) | 98,819 |
| Open | 7.96 |
| Previous Close | 8.10 |
| Day's Range | 7.79 - 8.20 |
| 52-Week Range | 3.96 - 8.56 |
| Beta | 0.32 |
About FENC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FENC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FENC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-11.19%
Fennec Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
6 months ago
-11.92%
Fennec Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 financial results.
2 weeks ago · seekingalpha.com
Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call TranscriptFennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Robert Andrade - Chief Financial Officer Jeff Hackman - Chief Executive Officer...
2 months ago · seekingalpha.com
Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call TranscriptFennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Robert Andrade - CFO Jeff Hackman - CEO and Board Member Conference Call Part...
